UMN to progress first combined rotavirus/norovirus vaccine following Finnish deal
This article was originally published in Scrip
Executive Summary
The private Japanese vaccine venture UMN Pharma has acquired worldwide rights to develop and commercialise a candidate combined prophylactic vaccine against norovirus and rotavirus infections.